About Medizinische Universitaetsklinik I at the University of Cologne
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
14
German CLL Study Group
8
German High-Grade Non-Hodgkin's Lymphoma Study Group
4
Pfizer
4
University of Minnesota
4
European Organisation for Research and Treatment of Cancer - EORTC
3
University of Heidelberg Medical Center
3
Boehringer Ingelheim
2
Heinrich-Heine University, Duesseldorf
2
Apogenix AG
1
Christine Mauz-Körholz
1
Clinical Trials at Medizinische Universitaetsklinik I at the University of Cologne
During the past decade, Medizinische Universitaetsklinik I at the University of Cologne conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 15 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Adjuvant Radiation Therapy in Treating Patients With Brain Metastases
1996-11-01
Terminated
340
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia
1997-07-01
Unknown status
1,000
Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma
2001-07-01
Unknown status
220
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
2001-01-01
2010-08-05
Completed
1,506
Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients
2003-01-01
Completed
328
Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
2003-04-01
2012-07-01
Completed
455
Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer
2002-04-01
Terminated
351
A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years
2004-01-01
2010-12-01
Completed
175
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Medizinische Universitaetsklinik I at the University of Cologne" #1 sponsor was "Hoffmann-La Roche" with 14 trials, followed by "German CLL Study Group" with 8 trials
sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials sponsored, "Pfizer" with 4 trials sponsored and "University of Minnesota"
with 4 trials sponsored. Other sponsors include 19 different institutions and
companies that sponsored additional 23 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Medizinische Universitaetsklinik I at the University of Cologne"
#1 collaborator was "German CLL Study Group" with 4 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator, "AbbVie" with 2 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator and "Medical Research Council" with 2 trials as a collaborator. Other collaborators include 39 different institutions and companies that were
collaborators in the rest 45 trials.
Clinical Trials Conditions at Medizinische Universitaetsklinik I at the University of Cologne
According to Clinical.Site data, the most researched conditions in "Medizinische Universitaetsklinik I at the University of Cologne" are
"Chronic Lymphocytic Leukemia" (11 trials), "Lymphoma" (8 trials), "Rheumatoid Arthritis" (5 trials), "Leukemia" (4 trials) and "Myelodysplastic Syndromes" (3 trials). Many other conditions were trialed in "Medizinische Universitaetsklinik I at the University of Cologne" in a lesser frequency.
Clinical Trials Intervention Types at Medizinische Universitaetsklinik I at the University of Cologne
Most popular intervention types in "Medizinische Universitaetsklinik I at the University of Cologne" are "Drug" (52 trials), "Biological" (17 trials), "Procedure" (6 trials), "Radiation" (6 trials) and "Other" (5 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (10 trials), "doxorubicin hydrochloride" (8 trials), "vincristine sulfate" (7 trials), "Cyclophosphamide" (6 trials) and "Placebo" (6 trials). Other intervention names were less common.
Clinical Trials Genders at Medizinische Universitaetsklinik I at the University of Cologne
The vast majority of trials in "Medizinische Universitaetsklinik I at the University of Cologne" are
56 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Medizinische Universitaetsklinik I at the University of Cologne
Currently, there are NaN active trials in "Medizinische Universitaetsklinik I at the University of Cologne".
undefined are not yet recruiting,
4 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 39 completed trials in Medizinische Universitaetsklinik I at the University of Cologne,
undefined suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Medizinische Universitaetsklinik I at the University of Cologne, 4 "Phase 1"
clinical trials were conducted, 16 "Phase 2" clinical
trials and 31 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 2 trials that are defined as “Not Applicable".